Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
TALTZ (AUTHORIZED: PSORIASIS)
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
||
|
WHO-ATC |
L04AC13
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
||
|
NDF-RT |
N0000191495
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
BTY153760O
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
PRIMARY | |||
|
CHEMBL1743034
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
PRIMARY | |||
|
1143503-69-8
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
PRIMARY | |||
|
m11937
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
PRIMARY | |||
|
IXEKIZUMAB
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
PRIMARY | |||
|
BTY153760O
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
PRIMARY | |||
|
C174646
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
PRIMARY | |||
|
Ixekizumab
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
PRIMARY | |||
|
5083
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
PRIMARY | |||
|
XX-56
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
PRIMARY | |||
|
100000162570
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
PRIMARY | |||
|
N0000191494
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
PRIMARY | Interleukin-17A Antagonists [MoA] | ||
|
DB11569
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
PRIMARY | |||
|
SUB176389
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
PRIMARY | |||
|
1745099
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
PRIMARY | |||
|
9467
Created by
admin on Sat Dec 16 12:00:04 UTC 2023 , Edited by admin on Sat Dec 16 12:00:04 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
